Researchers make breakthrough in arthritis research
Researchers at Western University have made a breakthrough that could lead to a better understanding of a common form of arthritis that, until now, has eluded scientists.
Medical research
Dec 03, 2012 |
5 / 5 (1) |
0
|
Diabetes leading to blindness in many people
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...
Diabetes
Nov 30, 2012 |
not rated yet |
0
Intermountain Healthcare Cancer research provides possible road map for improving healthcare
Given the right equipment, training and skill, an individual surgeon can expect to provide the best possible care on a consistent basis. But how do you get an entire system of surgeons—each with his or her own ideas, backgrounds, ...
Health
Nov 30, 2012 |
not rated yet |
0
Suvorexant drug may offer new approach to treating insomnia
A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
Neuroscience
Nov 28, 2012 |
not rated yet |
0
|
Patient's own immune cells may blunt viral therapy for brain cancer
Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors. Clinical trials show that these therapeutic viruses are safe but less effective than expected.
Cancer
Nov 25, 2012 |
3.7 / 5 (3) |
0
|
Nearly 90 percent of clinical trialists think data should be more easily shared
Nearly nine out of ten clinicians carrying out biomedical research trials believe that trial data should be shared more easily, even though they do express some practical concerns, a study published today on BMJ website reveal ...
Health
Nov 20, 2012 |
not rated yet |
0
Optimal dose suggested for dasatinib in ovarian cancer
(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, ...
Cancer
Nov 19, 2012 |
5 / 5 (1) |
0
Heart failure in older breast cancer patients linked to medication
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report ...
Cardiology
Nov 14, 2012 |
not rated yet |
0
|
Micro-needle array: New method for delivering the drug into the body just by attaching it onto the skin
Fujifilm Corporation has developed the micro-needle array which is a new drug administration method that has gained attention for delivering the drug into the body just by attaching it onto the skin.
Medical research
Nov 14, 2012 |
5 / 5 (1) |
0
Early changes in liver function could detect life-threatening infection
Early changes in liver function detected by novel techniques can identify severe infection (sepsis) hours after onset and so could have important implications for the treatment of patients who are critically ill, according ...
Medical research
Nov 13, 2012 |
not rated yet |
0
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
The simultaneous inhibition of two separate and seemingly unrelated pathways could potentially provide an effective treatment for women with triple-negative breast cancer, according to results of two studies published in ...
Cancer
Nov 12, 2012 |
4 / 5 (2) |
0
Exome sequencing: Potential diagnostic assay for unexplained intellectual disability
Research findings confirming that de novo mutations represent a major cause of previously unexplained intellectual disability were presented on Nov. 8 at the American Society of Human Genetics 2012 meeting in San Francisco.
Genetics
Nov 08, 2012 |
5 / 5 (1) |
0
Heart failure patients may be at higher risk for cancer: study
(HealthDay)—People suffering from heart failure may have a nearly 60 percent higher risk of developing cancer, a preliminary study suggests.
Cardiology
Nov 07, 2012 |
not rated yet |
0
New drug target found for cystic fibrosis lung disease
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential ...
Inflammatory disorders
Nov 07, 2012 |
5 / 5 (1) |
0
Hunting for the last remaining tumour cell
The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or ...
Cancer
Oct 29, 2012 |
not rated yet |
0
